Skip to main content

Table 4 Percent inhibition at 10 uM against RET, Kit, c-Met, VEGFR-1, VEGFR-2, FGFR1, PDGFR and BRAF achieved by compound 15c.

From: Discovery of a new potent oxindole multi-kinase inhibitor among a series of designed 3-alkenyl-oxindoles with ancillary carbonic anhydrase inhibitory activity as antiproliferative agents